Ravi Goud

Risk of Guillain-Barré Syndrome Following Recombinant Zoster Vaccine in Medicare Beneficiaries.

S. Anderson, R. Forshee, T. MaCurdy, 2021, JAMA internal medicine.

Postlicensure Safety Surveillance of Recombinant Zoster Vaccine (Shingrix) — United States, October 2017–June 2018

T. Shimabukuro, John R Su, Paige W. Lewis, 2019, MMWR. Morbidity and mortality weekly report.

Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)

Ravi Goud, N. Nair, Wambui Chege, 2021, Vaccine.

Notes from the Field: Vaccine Administration Errors Involving Recombinant Zoster Vaccine — United States, 2017–2018

R. Strikas, T. Shimabukuro, M. Cano, 2018, MMWR. Morbidity and mortality weekly report.

Decision support environment for medical product safety surveillance

Wei Wang, Abhishek Pandey, Taxiarchis Botsis, 2016, J. Biomed. Informatics.

Novel Algorithms for Improved Pattern Recognition Using the US FDA Adverse Event Network Analyzer

Robert Ball, Taxiarchis Botsis, John Scott, 2014, MIE.